Sernia, Conrad and Brown, Lindsay (2011) Emerging benefits of AT1 receptor antagonists with pleiotropic anti-inflammatory activity. American Journal of Hypertension, 24 (7). p. 739. ISSN 0895-7061
Metadata
| HTML Citation | EndNote | MODS | Dublin Core | Reference Manager |
Full text not available from this archive.
Identification Number or DOI: doi: 10.1038/ajh.2011.61
Abstract
In summary, angiotensin receptor antagonists with pleiotropic properties, such as telmisartan, have a great deal to recommend them in the treatment of the metabolic syndrome: they are antihypertensive, anti-inflammatory, may lower blood glucose concentrations, and normalize lipid homeostasis.
| Item Type: | Article (Commonwealth Reporting Category C) |
|---|---|
| Additional Information: | Permanent restricted access to published version due to publisher copyright policy. Note this is a C4 publication. |
| Uncontrolled Keywords: | metabolic syndrome; angiotensin receptor antagonists |
| Fields of Research (FOR2008): | 11 Medical and Health Sciences > 1103 Clinical Sciences > 110306 Endocrinology 11 Medical and Health Sciences > 1101 Medical Biochemistry and Metabolomics > 110107 Metabolic Medicine 06 Biological Sciences > 0606 Physiology > 060699 Physiology not elsewhere classified |
| Subjects: | UNSPECIFIED |
| Socio-Economic Objective (SEO2008): | C Society > 92 Health > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920104 Diabetes |
| ID Code: | 19930 |
| Deposited By: | |
| Deposited On: | 08 Feb 2012 16:33 |
| Last Modified: | 23 Apr 2012 15:23 |
Archive Staff Only: edit this record